US2891091A
(en)
|
1957-06-03 |
1959-06-16 |
Canadian Patents Dev |
Derivatives of para-aminosalicylic acid
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
US4002531A
(en)
|
1976-01-22 |
1977-01-11 |
Pierce Chemical Company |
Modifying enzymes with polyethylene glycol and product produced thereby
|
US4319039A
(en)
|
1979-06-15 |
1982-03-09 |
Merck & Co., Inc. |
Preparation of ammonium salt of hypocholesteremic fermentation product
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
US4294926A
(en)
|
1979-06-15 |
1981-10-13 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
US4444784A
(en)
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
DK149080C
(da)
|
1980-06-06 |
1986-07-28 |
Sankyo Co |
Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
|
ZA821577B
(en)
|
1981-04-06 |
1983-03-30 |
Boots Co Plc |
Therapeutic agents
|
JPS5889191A
(ja)
|
1981-11-20 |
1983-05-27 |
Sankyo Co Ltd |
3−ヒドロキシ−ml−236b誘導体の製造法
|
CA1258454A
(en)
|
1982-08-10 |
1989-08-15 |
Leo Alig |
Phenethanolamines
|
IT1159765B
(it)
|
1982-09-28 |
1987-03-04 |
Zanussi A Spa Industrie |
Macchina lavabiancheria di tipo modulare
|
US5354772A
(en)
|
1982-11-22 |
1994-10-11 |
Sandoz Pharm. Corp. |
Indole analogs of mevalonolactone and derivatives thereof
|
US4911165A
(en)
|
1983-01-12 |
1990-03-27 |
Ethicon, Inc. |
Pliabilized polypropylene surgical filaments
|
US4681893A
(en)
|
1986-05-30 |
1987-07-21 |
Warner-Lambert Company |
Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
|
US4885314A
(en)
|
1987-06-29 |
1989-12-05 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
US4782084A
(en)
|
1987-06-29 |
1988-11-01 |
Merck & Co., Inc. |
HMG-COA reductase inhibitors
|
US4820850A
(en)
|
1987-07-10 |
1989-04-11 |
Merck & Co., Inc. |
Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
|
US5180589A
(en)
|
1988-03-31 |
1993-01-19 |
E. R. Squibb & Sons, Inc. |
Pravastatin pharmaceuatical compositions having good stability
|
US5030447A
(en)
|
1988-03-31 |
1991-07-09 |
E. R. Squibb & Sons, Inc. |
Pharmaceutical compositions having good stability
|
WO1990000194A1
(en)
|
1988-06-28 |
1990-01-11 |
La Jolla Cancer Research Foundation |
Suppression of cell proliferation by decorin
|
US5026685A
(en)
|
1988-07-15 |
1991-06-25 |
The Salk Institute For Biological Studies |
NPY peptide analogs
|
US4916239A
(en)
|
1988-07-19 |
1990-04-10 |
Merck & Co., Inc. |
Process for the lactonization of mevinic acids and analogs thereof
|
US5290946A
(en)
|
1988-10-13 |
1994-03-01 |
Sandoz Ltd. |
Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
|
US5118853A
(en)
|
1988-10-13 |
1992-06-02 |
Sandoz Ltd. |
Processes for the synthesis of 3-disubstituted aminoacroleins
|
US5349052A
(en)
|
1988-10-20 |
1994-09-20 |
Royal Free Hospital School Of Medicine |
Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
|
WO1990005525A1
(en)
|
1988-11-23 |
1990-05-31 |
Pfizer Inc. |
Quinuclidine derivatives as substance p antagonists
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
US4929437A
(en)
|
1989-02-02 |
1990-05-29 |
Merck & Co., Inc. |
Coenzyme Q10 with HMG-CoA reductase inhibitors
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
US5189164A
(en)
|
1989-05-22 |
1993-02-23 |
Sandoz Ltd. |
Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
PH27357A
(en)
|
1989-09-22 |
1993-06-21 |
Fujisawa Pharmaceutical Co |
Pyrazole derivatives and pharmaceutical compositions comprising the same
|
US5232929A
(en)
|
1990-11-28 |
1993-08-03 |
Pfizer Inc. |
3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
|
WO1991009844A1
(en)
|
1990-01-04 |
1991-07-11 |
Pfizer Inc. |
Substance p antagonists
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
US5420245A
(en)
|
1990-04-18 |
1995-05-30 |
Board Of Regents, The University Of Texas |
Tetrapeptide-based inhibitors of farnesyl transferase
|
ES2063507T3
(es)
|
1990-06-01 |
1995-01-01 |
Pfizer |
3-amino-2-aril-quinuclidinas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
|
ATE116317T1
(de)
|
1990-07-23 |
1995-01-15 |
Pfizer |
Chinuclidinderivate.
|
WO1994004494A1
(en)
|
1992-08-13 |
1994-03-03 |
Warner-Lambert Company |
Tachykinin antagonists
|
WO1992006079A1
(en)
|
1990-09-28 |
1992-04-16 |
Pfizer Inc. |
Fused ring analogs of nitrogen containing nonaromatic heterocycles
|
AU652407B2
(en)
|
1991-01-10 |
1994-08-25 |
Pfizer Inc. |
N-alkyl quinuclidinium salts as substance P antagonists
|
ATE154354T1
(de)
|
1991-02-11 |
1997-06-15 |
Merck Sharp & Dohme |
Azabicyclische verbindungen, diese enthaltende pharmazeutische zubereitungen und ihre therapeutische verwendung
|
WO1992015585A1
(en)
|
1991-03-01 |
1992-09-17 |
Pfizer Inc. |
1-azabicyclo[3.2.2]nonan-3-amine derivatives
|
RU2105001C1
(ru)
|
1991-03-26 |
1998-02-20 |
Пфайзер Инк. |
Способ получения замещенных 3-аминопиперидинов
|
CA2109415C
(en)
|
1991-05-22 |
1998-12-29 |
Fumitaka Ito |
Substituted 3-aminoquinuclidines
|
WO1992020661A1
(en)
|
1991-05-22 |
1992-11-26 |
Merck & Co., Inc. |
N, n-diacylpiperazines
|
PL171379B1
(en)
|
1991-05-31 |
1997-04-30 |
Pfizer |
Method of obtaining novel derivatives of quinuclidine
|
GB9113219D0
(en)
|
1991-06-19 |
1991-08-07 |
Fujisawa Pharmaceutical Co |
Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
|
DE9290083U1
(de)
|
1991-06-20 |
1994-02-17 |
Pfizer Inc., New York, N.Y. |
Fluoralkoxybenzylamino-Derivate von stickstoffhaltigen Heterocyclen
|
TW202432B
(de)
|
1991-06-21 |
1993-03-21 |
Pfizer |
|
US5472978A
(en)
|
1991-07-05 |
1995-12-05 |
Merck Sharp & Dohme Ltd. |
Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
|
WO1993001159A1
(en)
|
1991-07-10 |
1993-01-21 |
Merck Sharp & Dohme Limited |
Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
|
EP0593615B1
(de)
|
1991-07-10 |
1996-01-31 |
MERCK SHARP & DOHME LTD. |
Aromatische verbindungen diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische verwendung
|
EP0600952B1
(de)
|
1991-08-20 |
1996-04-17 |
MERCK SHARP & DOHME LTD. |
Azacyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
|
WO1993006099A1
(en)
|
1991-09-16 |
1993-04-01 |
Pfizer Inc. |
Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists
|
WO1993009116A1
(en)
|
1991-11-07 |
1993-05-13 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Quinuclidine compound and medicinal use thereof
|
US5521220A
(en)
|
1991-11-12 |
1996-05-28 |
Pfizer Inc. |
Acyclic ethylenediamine derivatives
|
HU217629B
(hu)
|
1991-12-12 |
2000-03-28 |
Novartis Ag. |
Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
|
GB9200535D0
(en)
|
1992-01-10 |
1992-02-26 |
Fujisawa Pharmaceutical Co |
New compound
|
GB9201179D0
(en)
|
1992-01-21 |
1992-03-11 |
Glaxo Group Ltd |
Chemical compounds
|
US5328927A
(en)
|
1992-03-03 |
1994-07-12 |
Merck Sharpe & Dohme, Ltd. |
Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
|
JP2656702B2
(ja)
|
1992-03-23 |
1997-09-24 |
ファイザー製薬株式会社 |
ペプチド性キヌクリジン
|
FR2689888B1
(fr)
|
1992-04-10 |
1994-06-10 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
AU675786B2
(en)
|
1992-04-15 |
1997-02-20 |
Merck Sharp & Dohme Limited |
Azacyclic compounds
|
DK0641328T3
(da)
|
1992-05-18 |
2002-05-21 |
Pfizer |
Broforbundne, azabicykliske derivater som substans P-antagonister
|
GB9211193D0
(en)
|
1992-05-27 |
1992-07-08 |
Merck Sharp & Dohme |
Therapeutic agents
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US5637699A
(en)
|
1992-06-29 |
1997-06-10 |
Merck & Co., Inc. |
Process for preparing morpholine tachykinin receptor antagonists
|
CA2099233A1
(en)
|
1992-06-29 |
1993-12-30 |
Conrad P. Dorn |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
US5612336A
(en)
|
1992-07-13 |
1997-03-18 |
Merck, Sharp & Dohme Ltd. |
Heterocyclic amide derivatives as tachykinin antagonists
|
EP0786522A2
(de)
|
1992-07-17 |
1997-07-30 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatische RNA-Moleküle zur Behandlung von stenotischen Zuständen
|
ES2124318T3
(es)
|
1992-07-28 |
1999-02-01 |
Merck Sharp & Dohme |
Compuestos azaciclicos.
|
WO1994003429A1
(en)
|
1992-07-31 |
1994-02-17 |
Merck Sharp & Dohme Limited |
Substituted amines as tachykinin receptor antagonists
|
WO1994003445A1
(en)
|
1992-08-04 |
1994-02-17 |
Pfizer Inc. |
3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
|
DE69331103T2
(de)
|
1992-08-19 |
2002-03-14 |
Pfizer |
Substituierte benzylamin-stickstoff enthaltende nichtaromatische heterocyclen
|
US5387595A
(en)
|
1992-08-26 |
1995-02-07 |
Merck & Co., Inc. |
Alicyclic compounds as tachykinin receptor antagonists
|
US5563161A
(en)
|
1992-09-10 |
1996-10-08 |
Merck Sharp & Dohme Ltd. |
Alcohols and ethers with aromatic substituents as tachykinin-antagonists
|
GB9220286D0
(en)
|
1992-09-25 |
1992-11-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
JP2656699B2
(ja)
|
1992-10-21 |
1997-09-24 |
ファイザー製薬株式会社 |
置換ベンジルアミノキヌクリジン
|
GB9222262D0
(en)
|
1992-10-23 |
1992-12-09 |
Merck Sharp & Dohme |
Therapeutic agents
|
AU678409B2
(en)
|
1992-10-28 |
1997-05-29 |
Merck Sharp & Dohme Limited |
4-arylmethyloxymethyl piperidines as tachykinin antagonists
|
JP2656700B2
(ja)
|
1992-10-28 |
1997-09-24 |
ファイザー製薬株式会社 |
置換キヌクリジン誘導体
|
US5554627A
(en)
|
1992-10-30 |
1996-09-10 |
Merck, Sharp & Dohme Ltd. |
Tachykinin antagonists
|
JP2668164B2
(ja)
|
1992-11-12 |
1997-10-27 |
ファイザー・インク. |
P物質拮抗薬としてのキヌクリジン誘導体
|
ATE194340T1
(de)
|
1992-12-10 |
2000-07-15 |
Pfizer |
Aminomethylen substituierte heterocyclische verbindungen und ihre verwendung alssubstanz p antagonisten
|
US5536716A
(en)
|
1992-12-11 |
1996-07-16 |
Merck & Co., Inc. |
Spiro piperidines and homologs which promote release of growth hormone
|
US5604260A
(en)
|
1992-12-11 |
1997-02-18 |
Merck Frosst Canada Inc. |
5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
|
EP0673367A1
(de)
|
1992-12-14 |
1995-09-27 |
MERCK SHARP & DOHME LTD. |
4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenyl-piperidine als tachykinin rezeptor antagonisten
|
EP0604181A1
(de)
|
1992-12-21 |
1994-06-29 |
Eli Lilly And Company |
Antitumorpräparate und Behandlungsmethoden
|
GB9226581D0
(en)
|
1992-12-21 |
1993-02-17 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9300051D0
(en)
|
1993-01-04 |
1993-03-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
DE69406903T2
(de)
|
1993-01-15 |
1998-04-09 |
Searle & Co |
3,4-diarylthiophene und analoga davon, sowie deren verwendung als entzündungshemmende mittel
|
US5451677A
(en)
|
1993-02-09 |
1995-09-19 |
Merck & Co., Inc. |
Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
|
CA2152925A1
(en)
|
1993-02-18 |
1994-09-01 |
Raymond Baker |
Azacyclic compounds compositions containing them and their use as tachykinin antagonists
|
AU6140694A
(en)
|
1993-02-22 |
1994-09-14 |
Merck Sharp & Dohme Limited |
Aromatic compounds, compositions containing them and their use in therapy
|
WO1994019357A1
(en)
|
1993-02-23 |
1994-09-01 |
Merrell Dow Pharmaceuticals Inc. |
Farnesyl:protein transferase inhibitors as anticancer agents
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
US5298627A
(en)
|
1993-03-03 |
1994-03-29 |
Warner-Lambert Company |
Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
|
DE69318854T2
(de)
|
1993-03-04 |
1998-10-08 |
Pfizer |
Spiroazacyclischderivate als substanz p antagonisten
|
US5409944A
(en)
|
1993-03-12 |
1995-04-25 |
Merck Frosst Canada, Inc. |
Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
|
JPH08510205A
(ja)
|
1993-03-29 |
1996-10-29 |
ユニバーシティ オブ シンシナティ |
Yyペプチドのアナログとその用途
|
CA2118985A1
(en)
|
1993-04-02 |
1994-10-03 |
Dinesh V. Patel |
Heterocyclic inhibitors of farnesyl protein transferase
|
US5496833A
(en)
|
1993-04-13 |
1996-03-05 |
Merck Sharp & Dohme Limited |
Piperidine tachykinin receptor antagonists
|
CN1081635C
(zh)
|
1993-05-06 |
2002-03-27 |
默里尔药物公司 |
取代的吡咯烷 -3-基-烷基-哌啶
|
AU6909194A
(en)
|
1993-05-14 |
1994-12-12 |
Board Of Regents, The University Of Texas System |
Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole
|
US5602098A
(en)
|
1993-05-18 |
1997-02-11 |
University Of Pittsburgh |
Inhibition of farnesyltransferase
|
IL109646A0
(en)
|
1993-05-19 |
1994-08-26 |
Pfizer |
Heteroatom substituted alkyl benzylamino-quinuclidines
|
US5380738A
(en)
|
1993-05-21 |
1995-01-10 |
Monsanto Company |
2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
|
JPH08511522A
(ja)
|
1993-06-07 |
1996-12-03 |
メルク エンド カンパニー インコーポレーテッド |
ニューロキニンアンタゴニストとしてのスピロ置換アザ環
|
US5436265A
(en)
|
1993-11-12 |
1995-07-25 |
Merck Frosst Canada, Inc. |
1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
|
US5474995A
(en)
|
1993-06-24 |
1995-12-12 |
Merck Frosst Canada, Inc. |
Phenyl heterocycles as cox-2 inhibitors
|
GB9602877D0
(en)
|
1996-02-13 |
1996-04-10 |
Merck Frosst Canada Inc |
3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors
|
DK0708771T3
(da)
|
1993-07-15 |
1999-06-21 |
Pfizer |
Benzyloxyquinuclidiner som substans P antagonister
|
TW365603B
(en)
|
1993-07-30 |
1999-08-01 |
Rhone Poulenc Rorer Sa |
Novel perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
|
GB9315808D0
(en)
|
1993-07-30 |
1993-09-15 |
Merck Sharp & Dohme |
Therapeutic agents
|
HU224350B1
(hu)
|
1993-08-09 |
2005-08-29 |
Société de Conseils de Recherches et d'ApplicationScientifiques, S.A.S. Á |
Gyógyhatású peptidszármazékok
|
GB9317618D0
(en)
|
1993-08-24 |
1993-10-06 |
Royal Free Hosp School Med |
Polymer modifications
|
GB9317987D0
(en)
|
1993-08-26 |
1993-10-13 |
Glaxo Group Ltd |
Chemical compounds
|
EP0719253B1
(de)
|
1993-09-17 |
2004-04-28 |
Pfizer Inc. |
3-amino-5-carboxy-substituierte piperidine und 3-amino-4-carboxy-substituierte pyrrolidine als tachykinin-antagonisten
|
EP1209157A1
(de)
|
1993-09-17 |
2002-05-29 |
Pfizer Inc. |
Durch Geteroarylamion- und Heteroarylsulfonamido substituierte 3-Benzylaminomethylpiperidine und verwandte Derivate
|
EP0670314A4
(de)
|
1993-09-22 |
1996-04-10 |
Kyowa Hakko Kogyo Kk |
Farnesyltransferase inhibitoren.
|
IS4208A
(is)
|
1993-09-22 |
1995-03-23 |
Glaxo Group Limited |
3-(tetrazólýl-benzyl)amínó-piperadidín afleiður
|
HUT76057A
(en)
|
1993-10-15 |
1997-06-30 |
Schering Corp |
Tricyclic sulfonamide compounds, pharmaceutical compositions containing them, which are useful for inhibition of g-protein function and for treatment of proliferative diseases and process for producing them
|
US5661152A
(en)
|
1993-10-15 |
1997-08-26 |
Schering Corporation |
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5719148A
(en)
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
US5721236A
(en)
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
JP2875393B2
(ja)
|
1993-10-15 |
1999-03-31 |
シェーリング コーポレイション |
G−タンパク質機能の阻害および増殖性疾患の治療に有用な三環式カルバメート化合物
|
IL111235A
(en)
|
1993-10-15 |
2001-03-19 |
Schering Plough Corp |
Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
|
US5965566A
(en)
|
1993-10-20 |
1999-10-12 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
DE69427127T2
(de)
|
1993-10-25 |
2001-10-04 |
Parke Davis & Co |
Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase
|
AU7947594A
(en)
|
1993-10-27 |
1995-05-22 |
Merck Sharp & Dohme Limited |
Substituted amides as tachykinin antagonists
|
US5344991A
(en)
|
1993-10-29 |
1994-09-06 |
G.D. Searle & Co. |
1,2 diarylcyclopentenyl compounds for the treatment of inflammation
|
ATE177420T1
(de)
|
1993-11-04 |
1999-03-15 |
Abbott Lab |
Cyclobutan-derivate als inhibitoren der squalen- synthetase und der protein-farnesyltransferase
|
US5783593A
(en)
|
1993-11-04 |
1998-07-21 |
Abbott Laboratories |
Inhibitors of squalene synthetase and protein farnesyltransferase
|
HUT75308A
(en)
|
1993-11-05 |
1997-05-28 |
Warner Lambert Co |
Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
US5466823A
(en)
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
IT1271462B
(it)
|
1993-12-03 |
1997-05-28 |
Menarini Farma Ind |
Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
|
US5484799A
(en)
|
1993-12-09 |
1996-01-16 |
Abbott Laboratories |
Antifungal dorrigocin derivatives
|
FR2714057B1
(fr)
|
1993-12-17 |
1996-03-08 |
Sanofi Elf |
Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
|
IL111960A
(en)
|
1993-12-17 |
1999-12-22 |
Merck & Co Inc |
Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
|
AU1339795A
(en)
|
1993-12-21 |
1995-07-10 |
Eli Lilly And Company |
Non-peptide tachykinin receptor antagonists
|
PL179435B1
(pl)
|
1993-12-29 |
2000-09-29 |
Pfizer |
Diazabicykliczni antagonisci neurokininy PL
|
SG52217A1
(en)
|
1993-12-29 |
1998-09-28 |
Merck Sharp & Dohme |
Substituted morpholine derivatives and their use as therapeutic agents
|
AU685212B2
(en)
|
1994-01-13 |
1998-01-15 |
Merck Sharp & Dohme Limited |
Gem-disubstituted azacyclic tachykinin antagonists
|
CA2181376A1
(en)
|
1994-01-28 |
1995-08-03 |
Malcolm Maccoss |
Aralkylamino substituted azacyclic therapeutic agents
|
US5393790A
(en)
|
1994-02-10 |
1995-02-28 |
G.D. Searle & Co. |
Substituted spiro compounds for the treatment of inflammation
|
GB9402688D0
(en)
|
1994-02-11 |
1994-04-06 |
Merck Sharp & Dohme |
Therapeutic agents
|
US5610165A
(en)
|
1994-02-17 |
1997-03-11 |
Merck & Co., Inc. |
N-acylpiperidine tachykinin antagonists
|
IL112778A0
(en)
|
1994-03-04 |
1995-05-26 |
Merck & Co Inc |
Substituted heterocycles, their preparation and pharmaceutical compositions containing them
|
WO1995024612A1
(de)
|
1994-03-07 |
1995-09-14 |
International Business Machines Corporation |
Verfahren und vorrichtung zur schnellen interpolation von zwischenwerten aus periodischen phasenverschobenen signalen und zur erkennung von defekten in einem drehkörper
|
HUT77406A
(hu)
|
1994-03-15 |
1998-04-28 |
Eisai Co., Ltd., |
1-(4-Amino-5-tio-pent-2-en)-il oldalláncot tartalmazó peptidomimetikumok és az ezeket tartalmazó gyógyszerkészítmények
|
FR2718136B1
(fr)
|
1994-03-29 |
1996-06-21 |
Sanofi Sa |
Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
|
HUT72440A
(en)
|
1994-03-31 |
1996-04-29 |
Bristol Myers Squibb Co |
Imidazole-containing inhibitors of farnesyl protein transferase and pharmaceutical compositions containing them
|
US5523430A
(en)
|
1994-04-14 |
1996-06-04 |
Bristol-Myers Squibb Company |
Protein farnesyl transferase inhibitors
|
US5610145A
(en)
|
1994-04-15 |
1997-03-11 |
Warner-Lambert Company |
Tachykinin antagonists
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
EP0758329A1
(de)
|
1994-05-05 |
1997-02-19 |
MERCK SHARP & DOHME LTD. |
Morpholin-derivate und deren verwendung als antagonisten von tachykininen
|
MX9605128A
(es)
|
1994-05-07 |
1997-08-30 |
Boehringer Ingelheim Kg |
Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
|
US5510510A
(en)
|
1994-05-10 |
1996-04-23 |
Bristol-Meyers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US5563255A
(en)
|
1994-05-31 |
1996-10-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
PT764163E
(pt)
|
1994-06-06 |
2002-03-28 |
Warner Lambert Co |
Antagonistas do receptor de taquiquinina (nk1)
|
CA2192389A1
(fr)
|
1994-06-10 |
1995-12-21 |
Bernard Baudoin |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
US5571792A
(en)
|
1994-06-30 |
1996-11-05 |
Warner-Lambert Company |
Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
|
GB9415996D0
(en)
|
1994-08-08 |
1994-09-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
WO1996005529A1
(en)
|
1994-08-09 |
1996-02-22 |
Micron Optics, Inc. |
Temperature compensated fiber fabry-perot filters
|
TW432061B
(en)
|
1994-08-09 |
2001-05-01 |
Pfizer Res & Dev |
Lactams
|
CA2155448A1
(en)
|
1994-08-11 |
1996-02-12 |
Katerina Leftheris |
Inhibitors of farnesyl protein transferase
|
AU3192395A
(en)
|
1994-08-11 |
1996-03-07 |
Banyu Pharmaceutical Co., Ltd. |
Substituted amide derivative
|
EP0805154A1
(de)
|
1994-08-12 |
1997-11-05 |
Banyu Pharmaceutical Co., Ltd. |
N,n-disubstituierte aminsäurederivate
|
JP2002502351A
(ja)
|
1994-08-15 |
2002-01-22 |
メルク シヤープ エンド ドーム リミテツド |
モルホリン誘導体及び治療薬としてそれらの使用
|
DE4429506B4
(de)
|
1994-08-19 |
2007-09-13 |
Degussa Gmbh |
Verfahren zur Extraktion natürlicher Carotinoid-Farbstoffe
|
DE4429653C2
(de)
|
1994-08-20 |
1997-04-03 |
Anton Dr More |
Konverter und Verfahren zum Frischen von Metallschmelzen insbesondere von Roheisen zu Stahl
|
CN1067385C
(zh)
|
1994-08-25 |
2001-06-20 |
默里尔药物公司 |
用于治疗变应性疾病的新的取代的哌啶类化合物
|
GB9417956D0
(en)
|
1994-09-02 |
1994-10-26 |
Merck Sharp & Dohme |
Therapeutic agents
|
ATE212981T1
(de)
|
1994-09-30 |
2002-02-15 |
Novartis Erfind Verwalt Gmbh |
1-acyl-4-aliphatische aminopiperidin verbindungen
|
US5696093A
(en)
|
1994-10-28 |
1997-12-09 |
Crc For Biopharmaceutical Research Pty Limited |
Method of treating nasal congestion using neuropeptide Y Y2 agonist peptides
|
BR9509610A
(pt)
|
1994-11-07 |
1997-10-28 |
Pfizer |
Ligandos específicos de neuropeptideo Y1
|
US5574010A
(en)
|
1994-11-14 |
1996-11-12 |
The Regents Of The University Of California |
Treatment of pancreatic tumors with peptide YY and analogs thereof
|
DE69507284T2
(de)
|
1994-11-22 |
1999-07-01 |
Philips Electronics Nv |
Halbleiter mit einem träger auf dem ein substrat mit einem halbleiter-element mittels einer klebeschicht und ein leiterbahn-muster befestigt sind
|
FR2727411B1
(fr)
|
1994-11-30 |
1997-01-03 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent
|
WO1996017861A1
(en)
|
1994-12-09 |
1996-06-13 |
Warner-Lambert Company |
Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
|
IL116323A0
(en)
|
1994-12-13 |
1996-03-31 |
Sandoz Ag |
Tachykinin antagonists their preparation and pharmaceutical compositions containing them
|
GB9426103D0
(en)
|
1994-12-23 |
1995-02-22 |
Merck Sharp & Dohme |
Therapeutic agents
|
AU703440B2
(en)
|
1995-01-09 |
1999-03-25 |
Magla International Ltd. |
Wear resistant image printing on latex surfaces
|
EP0802912B1
(de)
|
1995-01-12 |
2004-10-13 |
Glaxo Group Limited |
Piperidinderivate mit tachykinin-antagonistischer wirkung
|
WO1996021456A1
(en)
|
1995-01-12 |
1996-07-18 |
University Of Pittsburgh |
Inhibitors of prenyl transferases
|
FR2729390A1
(fr)
|
1995-01-18 |
1996-07-19 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
US5907030A
(en)
|
1995-01-25 |
1999-05-25 |
University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
JPH11501297A
(ja)
|
1995-01-31 |
1999-02-02 |
イーライ・リリー・アンド・カンパニー |
抗肥満症タンパク質
|
US5605886A
(en)
|
1995-01-31 |
1997-02-25 |
Eli Lilly And Company |
Anti-obesity proteins
|
EP0725079A1
(de)
|
1995-01-31 |
1996-08-07 |
Eli Lilly And Company |
Proteine gegen die Fettleibigkeit
|
US5554727A
(en)
|
1995-01-31 |
1996-09-10 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552522A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552523A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5559208A
(en)
|
1995-01-31 |
1996-09-24 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
FR2730492B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
FR2730491B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
US5633272A
(en)
|
1995-02-13 |
1997-05-27 |
Talley; John J. |
Substituted isoxazoles for the treatment of inflammation
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
GB9505492D0
(en)
|
1995-03-18 |
1995-05-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9505491D0
(en)
|
1995-03-18 |
1995-05-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
US5554641A
(en)
|
1995-03-20 |
1996-09-10 |
Horwell; David C. |
Nonpeptides as tachykinin antagonists
|
GB9505692D0
(en)
|
1995-03-21 |
1995-05-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5700806A
(en)
|
1995-03-24 |
1997-12-23 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5684013A
(en)
|
1995-03-24 |
1997-11-04 |
Schering Corporation |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
US5565568A
(en)
|
1995-04-06 |
1996-10-15 |
Eli Lilly And Company |
2-acylaminopropanamides as tachykinin receptor antagonists
|
MX9707561A
(es)
|
1995-04-07 |
1997-12-31 |
Schering Corp |
Compuestos de carbonil piperazinilo y piperidinilo.
|
IL117798A
(en)
|
1995-04-07 |
2001-11-25 |
Schering Plough Corp |
Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
|
US5891872A
(en)
|
1995-04-07 |
1999-04-06 |
Schering Corporation |
Tricyclic compounds
|
US5712280A
(en)
|
1995-04-07 |
1998-01-27 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
CA2217006C
(en)
|
1995-04-13 |
2001-05-22 |
Hoechst Marion Roussel, Inc. |
Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
IL118101A0
(en)
|
1995-05-03 |
1996-09-12 |
Abbott Lab |
Inhibitors of farnesyltransferase
|
US20020006964A1
(en)
|
1995-05-16 |
2002-01-17 |
Young James W. |
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
|
HUP9900822A3
(en)
|
1995-05-25 |
1999-11-29 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives, process for producing them, pharmaceutical compositions containing them and method for treating tachykinin-mediated diseases
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
AU6034296A
(en)
|
1995-06-16 |
1997-01-15 |
Warner-Lambert Company |
Tricyclic inhibitors of protein farnesyltransferase
|
GB9513117D0
(en)
|
1995-06-28 |
1995-08-30 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9513121D0
(en)
|
1995-06-28 |
1995-08-30 |
Merck Sharp & Dohme |
Therapeutic agents
|
DE69612003T2
(de)
|
1995-07-07 |
2001-06-21 |
Pfizer |
Substituierte benzolaktamverbindungen als substanz-p-antagonisten
|
FR2736641B1
(fr)
|
1995-07-10 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
AT402617B
(de)
|
1995-07-11 |
1997-07-25 |
Datacon Schweitzer & Zeindl Gm |
Anlage zum automatisierten, hermetischen anlage zum automatisierten, hermetischen verschliessen von gehäusen verschliessen von gehäusen
|
FR2736638B1
(fr)
|
1995-07-12 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
CH690163A5
(fr)
|
1995-07-28 |
2000-05-31 |
Symphar Sa |
Dérivés gem-diphosphonates substitués utiles en tant qu'agents anti-cancers.
|
TW340842B
(en)
|
1995-08-24 |
1998-09-21 |
Pfizer |
Substituted benzylaminopiperidine compounds
|
US6028052A
(en)
|
1995-09-18 |
2000-02-22 |
Ligand Pharmaceuticals Incorporated |
Treating NIDDM with RXR agonists
|
US6020343A
(en)
|
1995-10-13 |
2000-02-01 |
Merck Frosst Canada, Inc. |
(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
|
JP2002534955A
(ja)
|
1995-10-18 |
2002-10-15 |
メルク エンド カンパニー インコーポレーテッド |
シクロペンチルタキキニン受容体アンタゴニスト
|
DE19541283A1
(de)
|
1995-11-06 |
1997-05-07 |
Boehringer Ingelheim Kg |
Neue Aminosäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
ES2196186T3
(es)
|
1995-11-06 |
2003-12-16 |
Univ Pittsburgh |
Inhibidores de protein-isoprenil-transferasas.
|
GB9523244D0
(en)
|
1995-11-14 |
1996-01-17 |
Merck Sharp & Dohme |
Therapeutic agents
|
ES2218328T5
(es)
|
1995-11-17 |
2011-11-11 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
Derivados de epotilón, su preparación y utilización.
|
AU704139B2
(en)
|
1995-11-22 |
1999-04-15 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
AU715558B2
(en)
|
1995-11-23 |
2000-02-03 |
Merck Sharp & Dohme Limited |
Spiro-piperidine derivatives and their use as tachykinin antagonists
|
GB9524157D0
(en)
|
1995-11-25 |
1996-01-24 |
Pfizer Ltd |
Therapeutic agents
|
WO1997020820A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Heteroaryl compounds
|
WO1997019682A1
(en)
|
1995-12-01 |
1997-06-05 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
AU7692696A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Heteroaryl derivatives
|
AU7692996A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Receptor antagonists
|
AU7692896A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Quinazolin-2,4-diazirines as NPY receptor antagonist
|
DE69620445T2
(de)
|
1995-12-08 |
2002-12-12 |
Janssen Pharmaceutica Nv |
(imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
|
GB9525296D0
(en)
|
1995-12-11 |
1996-02-07 |
Merck Sharp & Dohme |
Therapeutic agents
|
SK86198A3
(en)
|
1995-12-22 |
1999-02-11 |
Schering Corp |
Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
AU1529997A
(en)
|
1996-01-16 |
1997-08-11 |
Warner-Lambert Company |
Substituted histidine inhibitors of protein farnesyltransferase
|
ATE293963T1
(de)
|
1996-02-02 |
2005-05-15 |
Merck & Co Inc |
Verfahren zur behandlung von diabetes und verwandter krankheitszustände.
|
JP2002503202A
(ja)
|
1996-02-02 |
2002-01-29 |
メルク エンド カンパニー インコーポレーテッド |
抗糖尿病薬
|
WO1997028149A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
ES2194179T3
(es)
|
1996-02-02 |
2003-11-16 |
Merck & Co Inc |
Derivados heterociclicos como agentes antidiabeticos y antiobesidad.
|
ATE262334T1
(de)
|
1996-02-02 |
2004-04-15 |
Merck & Co Inc |
Antidiabetisches mittel
|
WO1997029079A1
(fr)
|
1996-02-06 |
1997-08-14 |
Japan Tobacco Inc. |
Composes chimiques et utilisation pharmaceutique
|
US6673927B2
(en)
|
1996-02-16 |
2004-01-06 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Farnesyl transferase inhibitors
|
GB9606805D0
(en)
|
1996-03-30 |
1996-06-05 |
Glaxo Wellcome Inc |
Medicaments
|
WO1997038665A2
(en)
|
1996-04-03 |
1997-10-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
TR199802049T2
(xx)
|
1996-04-12 |
1999-01-18 |
G.D.Searle & Co. |
COX-2 Inhibit�rlerinin �nilac� olarak s�bstit�e edilmi� benzens�lfonamid t�revleri.
|
CZ376498A3
(cs)
|
1996-05-22 |
1999-02-17 |
Warner-Lambert Company |
Inhibitory proteinové farnesyl fransferázy
|
EP0906310A4
(de)
|
1996-06-07 |
1999-09-01 |
Merck & Co Inc |
Oxadiazol-benzosulfonamide als selektive beta-3 adrenergische rezeptor agonisten zur behandlung von diabetis und fettleibigkeit
|
PL330235A1
(en)
|
1996-06-21 |
1999-05-10 |
Merck Sharp & Dohme |
Derivatives of spiropiperidine and their application as therapeutic agents
|
EP0918771A4
(de)
|
1996-07-15 |
2001-02-07 |
Bristol Myers Squibb Co |
Thiadioxobenzodiazepin-inhibitoren der farnesyl-protein-transferase
|
US5861419A
(en)
|
1996-07-18 |
1999-01-19 |
Merck Frosst Canad, Inc. |
Substituted pyridines as selective cyclooxygenase-2 inhibitors
|
US5981575A
(en)
*
|
1996-11-15 |
1999-11-09 |
Johns Hopkins University, The |
Inhibition of fatty acid synthase as a means to reduce adipocyte mass
|
IT1288388B1
(it)
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
EP1386922B1
(de)
|
1996-12-03 |
2012-04-11 |
Sloan-Kettering Institute For Cancer Research |
Synthese von Epitholonen, Zwischenprodukte, Analoga und ihre Verwendung
|
WO1998024768A1
(fr)
|
1996-12-03 |
1998-06-11 |
Banyu Pharmaceutical Co., Ltd. |
Nouveaux derives d'uree
|
DE69719544T2
(de)
|
1996-12-12 |
2003-11-06 |
Banyu Pharma Co Ltd |
Pyrazolderivate
|
EP0945439B1
(de)
|
1996-12-13 |
2003-03-19 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyrazolderivate
|
DE69729315T2
(de)
|
1996-12-16 |
2005-06-23 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyrazolderivate
|
EP1003374A1
(de)
|
1996-12-30 |
2000-05-31 |
Merck & Co., Inc. |
Inhibitoren von farnesyl-protein-transferase
|
JP2001507699A
(ja)
|
1996-12-30 |
2001-06-12 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル蛋白トランスフェラーゼ阻害薬
|
US6100259A
(en)
|
1997-01-21 |
2000-08-08 |
Smithkline Beecham Corporation |
Cannabinoid receptor modulators
|
AU728812B2
(en)
|
1997-01-28 |
2001-01-18 |
Merck & Co., Inc. |
Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity
|
AU5773798A
(en)
|
1997-01-29 |
1998-08-18 |
Polymasc Pharmaceuticals Plc |
Pegylation process
|
CN1982290A
(zh)
|
1997-02-04 |
2007-06-20 |
阿肯色大学评议会 |
杀菌的羧酰胺
|
NZ337331A
(en)
|
1997-02-21 |
2001-05-25 |
Bayer Ag |
Aryl-sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
|
WO1998040356A1
(fr)
|
1997-03-12 |
1998-09-17 |
Banyu Pharmaceutical Co., Ltd. |
Medicaments contenant des derives d'aminopyridine comme ingredient actif
|
WO1998041519A1
(en)
|
1997-03-18 |
1998-09-24 |
Smithkline Beecham Corporation |
Novel cannabinoid receptor agonists
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
AU7079498A
(en)
|
1997-04-23 |
1998-11-13 |
Banyu Pharmaceutical Co., Ltd. |
Neuropeptide y receptor antagonist
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
SE9702457D0
(sv)
|
1997-06-26 |
1997-06-26 |
Pharmacia & Upjohn Ab |
Screening
|
AU8127998A
(en)
|
1997-07-11 |
1999-02-08 |
Japan Tobacco Inc. |
Quinoline compounds and medicinal uses thereof
|
US6093692A
(en)
|
1997-09-25 |
2000-07-25 |
The University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
AU9185598A
(en)
|
1997-09-25 |
1999-04-12 |
Banyu Pharmaceutical Co., Ltd. |
Novel neuropeptide y receptor antagonists
|
AU1262199A
(en)
|
1997-11-28 |
1999-06-16 |
Banyu Pharmaceutical Co., Ltd. |
Antihyperlipemic agents
|
US6046167A
(en)
|
1998-03-25 |
2000-04-04 |
University Of Cincinnati |
Peptide YY analogs
|
EP1068207A1
(de)
|
1998-04-02 |
2001-01-17 |
Neurogen Corporation |
Aminoalkyl substituierte 9h-pyridino[2,3-b]indol- und 9h-pyrimidino[4,5-b]indol-derivate
|
IL139227A0
(en)
|
1998-04-29 |
2001-11-25 |
Ortho Mcneil Pharm Inc |
N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
US6294534B1
(en)
|
1998-06-11 |
2001-09-25 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
AU742425B2
(en)
|
1998-06-11 |
2002-01-03 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
US6365610B1
(en)
|
1998-07-29 |
2002-04-02 |
Taiho Pharmaceutical Company Ltd. |
Ozonide compounds with inhibitory activity for urokinase production and angiogenesis
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
ATE457169T1
(de)
|
1998-10-15 |
2010-02-15 |
Imp Innovations Ltd |
Verbindungen für die behandlung von gewichtsverlust
|
DE69929235T2
(de)
|
1998-11-10 |
2006-08-24 |
Merck & Co., Inc. |
Spiro-indole als y5-rezeptor antagonisten
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
IL144578A0
(en)
|
1999-01-29 |
2002-05-23 |
Imclone Systems Inc |
Antibodies specific to kdr and uses thereof
|
GB9904387D0
(en)
|
1999-02-25 |
1999-04-21 |
Pharmacia & Upjohn Spa |
Antitumour synergistic composition
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
JP2003519087A
(ja)
|
1999-03-19 |
2003-06-17 |
クノール・ゲー・エム・ベー・ハー |
摂食障害を治療する方法
|
AU4972900A
(en)
|
1999-04-08 |
2000-11-14 |
Arch Development Corporation |
Use of anti-vegf antibody to enhance radiation in cancer therapy
|
FR2792314B1
(fr)
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
JP2002543067A
(ja)
|
1999-04-22 |
2002-12-17 |
シナプティック・ファーマスーティカル・コーポレーション |
選択的なnpy(y5)のアンタゴニスト
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
EP1177172A1
(de)
|
1999-05-05 |
2002-02-06 |
Ortho-McNeil Pharmaceutical, Inc. |
3a,4,5,9b-tetrahydro-1h-benz[e]indol-2-yl amine-derivate als ligande von neuropeptide y rezeptoren zur behandlung der fettleibigkeit und andere störungen
|
EP1177188B1
(de)
|
1999-05-12 |
2005-10-12 |
Ortho-McNeil Pharmaceutical, Inc. |
Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
|
JP2003505435A
(ja)
|
1999-06-04 |
2003-02-12 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体ゴニストとしての置換ピペリジン
|
DK1194421T3
(da)
|
1999-06-30 |
2006-02-13 |
Lundbeck & Co As H |
Selektive NPY (Y5) antagonister
|
WO2001007409A1
(en)
|
1999-07-23 |
2001-02-01 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
RU2228927C2
(ru)
|
1999-07-28 |
2004-05-20 |
Орто-Макнейл Фармасьютикал, Инк. |
Производные аминов или амидов, фармацевтическая композиция на их основе и способ антагонизирования рецептора y5 нейропептида npy
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
US6462053B1
(en)
|
1999-08-20 |
2002-10-08 |
Banyu Pharmaceutical Co., Ltd. |
Spiro compounds
|
WO2001021577A2
(en)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Melanin concentrating hormone antagonist
|
WO2001021169A1
(fr)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Antagonistes de l'hormone de concentration de la melanine
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
PL354784A1
(en)
|
1999-09-30 |
2004-02-23 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
PL354982A1
(en)
|
1999-09-30 |
2004-03-22 |
Neurogen Corporation |
Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
EA200200422A1
(ru)
|
1999-09-30 |
2002-10-31 |
Ньюроджен Корпорейшн |
НЕКОТОРЫЕ АЛКИЛЕНДИАМИНОЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-а]-1,5-ПИРИМИДИНЫ И ПИРАЗОЛО[1,5-а]-1,3,5-ТРИАЗИНЫ
|
DE19949319A1
(de)
|
1999-10-13 |
2001-06-13 |
Ruetgers Vft Ag |
Verfahren zur Herstellung von Arylalkylethern
|
KR100524159B1
(ko)
|
1999-10-13 |
2005-10-25 |
화이자 프로덕츠 인코포레이티드 |
모노아민 재흡수 억제제로서 유용한 비아릴 에테르 유도체
|
US6545004B1
(en)
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
DE60028227T2
(de)
|
1999-10-27 |
2007-03-29 |
Cytokinetics, Inc., South San Francisco |
Chinazolinone benutzende verfahren und zusammenstellungen
|
IL149872A0
(en)
|
1999-12-16 |
2002-11-10 |
Schering Corp |
Substituted imidazole neuropeptide y y5 receptor antagonists
|
AU2001228325A1
(en)
|
2000-02-01 |
2001-08-14 |
Novo-Nordisk A/S |
Use of compounds for the regulation of food intake
|
JP2004502642A
(ja)
|
2000-02-11 |
2004-01-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
|
JP2001226269A
(ja)
|
2000-02-18 |
2001-08-21 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
ES2236178T3
(es)
|
2000-02-22 |
2005-07-16 |
Banyu Pharmaceutical Co., Ltd. |
Nuevos compuestos de imidazolina.
|
GB0004003D0
(en)
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
EP1132389A1
(de)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
Neue Azaindolyl-Derivate für die Behandlung von Fettleibigheit
|
BRPI0109200B8
(pt)
|
2000-03-14 |
2021-05-25 |
Actelion Pharmaceuticals Ltd |
compostos e composições farmacêuticas
|
EP1268000A4
(de)
|
2000-03-23 |
2004-12-29 |
Merck & Co Inc |
Spiropiperidinderivate als melanocortin-rezeptor agonisten
|
AU4929601A
(en)
|
2000-03-23 |
2001-10-03 |
Merck & Co Inc |
Substituted piperidines as melanocortin receptor agonists
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
EP1142886A1
(de)
|
2000-04-07 |
2001-10-10 |
Aventis Pharma Deutschland GmbH |
Perzychinnin, Verfahren zu ihrer Herstellung und ihre Verwendung als pharmazeutisches Produkt
|
ATE479429T1
(de)
|
2000-04-28 |
2010-09-15 |
Takeda Pharmaceutical |
Antagonisten des melanin-konzentrierenden hormons
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
WO2001085173A1
(en)
|
2000-05-10 |
2001-11-15 |
Bristol-Myers Squibb Company |
Alkylamine derivatives of dihydropyridine npy antagonists
|
DE60115227T2
(de)
|
2000-05-11 |
2006-08-24 |
Bristol-Myers Squibb Co. |
Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
|
US7229986B2
(en)
|
2000-05-16 |
2007-06-12 |
Takeda Pharmaceutical Company Ltd. |
Melanin-concentrating hormone antagonist
|
WO2001087335A2
(en)
|
2000-05-17 |
2001-11-22 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
EP1289526A4
(de)
|
2000-05-30 |
2005-03-16 |
Merck & Co Inc |
Agoniste des melanocortin-rezeptors
|
EP1289955B1
(de)
|
2000-06-16 |
2005-04-13 |
Smithkline Beecham Plc |
Piperidine zur verwendung als orexin rezeptor antagonisten
|
EP1299362A4
(de)
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
Selektive rezeptorantagonisten des melaninkonzentrierenden hormons-1 (mch1) und ihre anwendung
|
CA2414198A1
(en)
|
2000-07-06 |
2002-01-17 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands
|
GB0019357D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel phenyl guanidines
|
JP2004504406A
(ja)
|
2000-07-24 |
2004-02-12 |
アーダナ バイオサイエンス リミテッド |
グレリンアンタゴニスト
|
AU2001283955B2
(en)
|
2000-07-31 |
2006-05-18 |
F. Hoffmann-La Roche Ag |
Piperazine derivatives
|
US6768024B1
(en)
|
2000-08-04 |
2004-07-27 |
Lion Bioscience Ag |
Triamine derivative melanocortin receptor ligands and methods of using same
|
GB0019359D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel guanidines
|
US20040006120A1
(en)
|
2000-08-21 |
2004-01-08 |
Yates Stephen L |
Use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity
|
WO2002015845A2
(en)
|
2000-08-21 |
2002-02-28 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
EP1320366A4
(de)
|
2000-08-23 |
2005-04-06 |
Merck & Co Inc |
Substituierte piperidine als melanocortin-rezeptoragonisten
|
EP1322628A2
(de)
|
2000-09-14 |
2003-07-02 |
Schering Corporation |
Substituierte harnstoffe als neuropeptid y y5 rezeptor antagonisten
|
CA2419388A1
(en)
|
2000-10-13 |
2002-04-25 |
Eli Lilly And Company |
Substituted dipeptides as growth hormone secretagogues
|
JP4047723B2
(ja)
|
2000-10-16 |
2008-02-13 |
エフ.ホフマン−ラ ロシュ アーゲー |
インドリン誘導体、および5−ht2受容体リガンドとしてのその使用
|
BR0114836A
(pt)
|
2000-10-20 |
2003-07-01 |
Pfizer Prod Inc |
Agonistas de receptores beta-3 adrenérgicos e suas aplicações
|
WO2002036596A2
(en)
|
2000-11-03 |
2002-05-10 |
Wyeth |
CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES
|
CA2448729A1
(en)
|
2000-11-20 |
2002-05-23 |
Biovitrum Ab |
Piperazinyl and piperidyl substituted heterocyclic compounds
|
CN1227237C
(zh)
|
2000-11-20 |
2005-11-16 |
比奥维特罗姆股份公司 |
作为五羟色胺5-ht2受体拮抗剂的哌嗪基吡嗪化合物
|
MXPA03004245A
(es)
|
2000-12-12 |
2003-09-22 |
Neurogen Corp |
Espiro[isobenzofuran-1,4'piperidin]-3-onas y 3h-espiroisobenzofuran-1,4'-piperidinas.
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
CN1482912A
(zh)
|
2000-12-21 |
2004-03-17 |
���鹫˾ |
杂芳基脲神经肽yy5受体拮抗剂
|
JP4025200B2
(ja)
|
2000-12-22 |
2007-12-19 |
シェーリング コーポレイション |
ピペリジンmchアンタゴニストおよび肥満の処置におけるそれらの使用
|
MXPA03005915A
(es)
|
2000-12-27 |
2003-09-10 |
Hoffmann La Roche |
Derivados de indol y su uso como ligandos receptores de 5-ht2b y 5-ht2c.
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
US7186715B2
(en)
|
2001-01-08 |
2007-03-06 |
Eli Lilly And Company |
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
|
US7169777B2
(en)
|
2001-01-23 |
2007-01-30 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
WO2002059107A1
(en)
|
2001-01-23 |
2002-08-01 |
Eli Lilly And Company |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
SK10802003A3
(sk)
|
2001-02-02 |
2004-05-04 |
Takeda Chemical Industries, Ltd. |
Kondenzovaná heterocyklická zlúčenina, jej použitie a jej farmaceutický prípravok
|
JP4323169B2
(ja)
|
2001-02-28 |
2009-09-02 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体作働薬としてのアシル化ピペリジン誘導体
|
CN1633297A
(zh)
|
2001-02-28 |
2005-06-29 |
麦克公司 |
作为黑皮质素-4受体激动剂的酰化哌啶衍生物
|
WO2002067869A2
(en)
|
2001-02-28 |
2002-09-06 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
MXPA03008484A
(es)
|
2001-03-21 |
2003-12-08 |
Pharmacopeia Inc |
Compuestos de arilo y biarilo que tienen actividad moduladora de hormona concentradora de melanina.
|
CZ2003698A3
(cs)
|
2001-03-22 |
2003-06-18 |
Solvay Pharmaceuticals B. V. |
4,5-Dihydro-1H-pyrazolové deriváty mající CB1-antagonistickou účinnost
|
AU782148B2
(en)
|
2001-03-29 |
2005-07-07 |
Molecular Design International, Inc. |
Beta3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
|
WO2002083138A1
(en)
|
2001-04-10 |
2002-10-24 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
US6960584B2
(en)
|
2001-04-10 |
2005-11-01 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
WO2002083139A1
(en)
|
2001-04-10 |
2002-10-24 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
US6958334B2
(en)
|
2001-04-10 |
2005-10-25 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
JP4280073B2
(ja)
|
2001-04-12 |
2009-06-17 |
ファーマコペイア ドラッグ ディスカバリー, インコーポレイテッド |
Mchアンタゴニストとして使用されるアリールピペリジンおよびビアリールピペリジン
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
WO2002094825A1
(fr)
|
2001-05-22 |
2002-11-28 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de spiropiperidine
|
MXPA03010612A
(es)
|
2001-05-22 |
2004-04-02 |
Neurogen Corp |
Ligandos receptores de la hormona concentradora de melanina: analogos de 1-bencil-4-aril piperazina substiruidos.
|
US7253172B2
(en)
|
2001-06-20 |
2007-08-07 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
AU2002344820B2
(en)
|
2001-06-20 |
2006-12-14 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
JP4357293B2
(ja)
|
2001-06-27 |
2009-11-04 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
|
DE60223920T2
(de)
|
2001-06-27 |
2008-11-13 |
Smithkline Beecham Corp. |
Pyrrolidine als dipeptidyl-peptidase-inhibitoren
|
WO2003002593A2
(en)
|
2001-06-27 |
2003-01-09 |
Probiodrug Ag |
Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis
|
WO2003002531A2
(en)
|
2001-06-27 |
2003-01-09 |
Smithkline Beecham Corporation |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
ATE388951T1
(de)
|
2001-07-03 |
2008-03-15 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
CN1671386A
(zh)
|
2001-07-05 |
2005-09-21 |
H·隆德贝克有限公司 |
作为mch选择性拮抗剂的取代苯胺基哌啶
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
JP4336196B2
(ja)
|
2001-07-18 |
2009-09-30 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体作動薬としての架橋ピペリジン誘導体
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
BRPI0104510B8
(pt)
|
2001-07-27 |
2021-05-25 |
Embrapa Pesquisa Agropecuaria |
peptídeos antibióticos da família das phylloseptinas isolados da secreção da pele de phylloseptina hypocondrialis e composição antimicrobiana relacionada
|
MXPA04001144A
(es)
|
2001-08-07 |
2004-07-08 |
Banyu Pharma Co Ltd |
Compuestos espiro.
|
WO2003013526A1
(en)
|
2001-08-08 |
2003-02-20 |
Merck & Co. Inc. |
Anticoagulant compounds
|
CA2461454A1
(en)
|
2001-09-24 |
2003-04-03 |
Oregon Health And Science University |
Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
|
PL205971B1
(pl)
|
2001-09-24 |
2010-06-30 |
Imp Innovations Ltd |
Zastosowanie PYY₃-₃₆ do wytwarzania leku na ograniczanie apetytu, zmniejszenie otyłości lub do zapobiegania otyłości
|
US7060705B2
(en)
|
2001-11-07 |
2006-06-13 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
CA2468156A1
(en)
|
2001-12-06 |
2003-06-19 |
Merck & Co., Inc. |
Azolopyrimidinone compounds and their use
|
AU2002364128B2
(en)
|
2001-12-06 |
2008-03-06 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
ATE424388T1
(de)
|
2001-12-06 |
2009-03-15 |
Merck & Co Inc |
Mitotische kinesinhemmer
|
CA2467916A1
(en)
|
2001-12-06 |
2003-06-19 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
DE60222302T2
(de)
|
2001-12-06 |
2008-05-29 |
Merck & Co., Inc. |
Inhibitoren von mitotischem kinesin
|
WO2003057235A2
(en)
|
2002-01-10 |
2003-07-17 |
Imperial College Innovations Ltd |
Modification of feeding behavior
|
NZ534757A
(en)
|
2002-03-12 |
2006-07-28 |
Merck & Co Inc |
Substituted amides
|
WO2003086279A2
(en)
|
2002-04-08 |
2003-10-23 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
EP1496896A4
(de)
|
2002-04-08 |
2007-10-31 |
Merck & Co Inc |
Akt-wirkungshemmer
|
WO2003086404A1
(en)
|
2002-04-08 |
2003-10-23 |
Merck & Co., Inc. |
Fused quinoxaline derivatives as inhibitors of akt activity
|
CA2480880C
(en)
|
2002-04-08 |
2011-03-22 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
JP2005320249A
(ja)
|
2002-05-01 |
2005-11-17 |
Banyu Pharmaceut Co Ltd |
2−アミノピラジン誘導体の製造方法
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
US7065367B2
(en)
|
2002-07-11 |
2006-06-20 |
Oliver Michaelis |
Interface selection in a wireless communication network
|
WO2004024720A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
US6869966B2
(en)
|
2002-09-30 |
2005-03-22 |
Banyu Pharmaceutical Co., Ltd. |
N-substituted-2-oxodihydropyridine derivatives
|
JP4253172B2
(ja)
|
2002-10-18 |
2009-04-08 |
東芝電池株式会社 |
密閉型ニッケル亜鉛一次電池
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
EP1583549A4
(de)
|
2003-01-17 |
2006-10-04 |
Sod Conseils Rech Applic |
Yy-peptid-analoga
|
WO2004078716A1
(en)
|
2003-03-03 |
2004-09-16 |
Merck & Co. Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
CA2519939A1
(en)
|
2003-03-26 |
2004-10-14 |
Merck & Co., Inc. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
RU2005134230A
(ru)
|
2003-04-04 |
2006-05-10 |
Мерк энд Ко., Инк. (US) |
Ацилированные производные спиропиперидина как агонисты рецептора меланокортина-4
|
CN1802351A
(zh)
|
2003-06-11 |
2006-07-12 |
麦克公司 |
被取代的3-烷基和3-链烯基氮杂环丁烷衍生物
|
EP1648457A2
(de)
|
2003-07-22 |
2006-04-26 |
Merck & Co., Inc. |
Piperidinderivate als melanocortin-4 rezeptoragonisten
|
AU2004259014B2
(en)
|
2003-07-24 |
2009-12-17 |
Merck Sharp & Dohme Corp. |
Antibiotic compound
|
CA2555824C
(en)
|
2004-02-13 |
2011-06-07 |
Banyu Pharmaceutical Co., Ltd. |
Fused-ring 4-oxopyrimidine derivative
|
BRPI0510397A
(pt)
|
2004-05-26 |
2007-11-13 |
Fasgen Llc |
compostos, composições farmacêuticas contendo os mesmos, e métodos de uso dos mesmos
|
WO2008039327A2
(en)
*
|
2006-09-22 |
2008-04-03 |
Merck & Co., Inc. |
Method of treatment using fatty acid synthesis inhibitors
|